CAM
ANGO icon

Capstone Asset Management’s AngioDynamics ANGO Stock Holding History

Capstone Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,226
Closed -$285K – 1614
2016
Q3 		$285K Buy
16,226
+460
+3% +$7.46K 0.01% 1339
2016
Q2 		$227K Hold
15,766
– – 0.01% 1452
2016
Q1 		$194K Sell
15,766
-540
-3% -$5.97K 0.01% 1502
2015
Q4 		$198K Buy
+16,306
New +$201K 0.01% 1512

Other funds holding ANGO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capstone Asset Management's ANGO Position: Q4 2016 in Review

Capstone Asset Management sold out of AngioDynamics (ANGO) in Q4 2016, closing a stake of 16,226 shares — an estimated $285K sold.

Capstone Asset Management first reported a position in ANGO in Q4 2015 and held it in 4 quarters. The position peaked at $285K in Q3 2016. 151 funds tracked by Wall St. Rank hold ANGO as of Q4 2016.

  • Capstone Asset Management reported no remaining AngioDynamics position as of Q4 2016 after selling out during the quarter.
  • Capstone Asset Management sold 16,226 AngioDynamics shares in Q4 2016, an estimated $285K.
  • Capstone Asset Management first reported a position in AngioDynamics in Q4 2015 and held it in 4 quarters.
  • Capstone Asset Management's AngioDynamics position peaked at $285K in Q3 2016.
  • 151 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2016.

Based on Capstone Asset Management's 13F filing for Q4 2016, filed 17 Jan 2017.